Stock-Based Compensation (Tables)

12 Months Ended

Oct. 29, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of reconciliation of the number of options outstanding and exercisable

A reconciliation of the number of options outstanding and exercisable as of October 29, 2023, is:

	Shares (in thousands)	Weighted-average Exercise Price		Weighted-average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Stock Options Outstanding at October 30, 2022	16,130	$	36.85
Granted	1,002	46.46
Exercised	(518)	29.24
Forfeited	(147)	41.51
Expired	(84)	42.55
Stock Options Outstanding at October 29, 2023	16,384	$	37.61	4.3	$	18,845
Stock Options Exercisable at October 29, 2023	13,611	$	36.00	3.5	$	18,845

Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised

The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised are:

	Fiscal Year Ended
	October 29,		October 30,		October 31,
In thousands, except per share amounts	2023		2022		2021
Weighted-average Grant Date Fair Value	$	10.06	$	7.09	$	7.52
Intrinsic Value of Exercised Options	6,350		109,745		94,108

Schedule of weighted-average assumptions used to calculate fair value of each option award

The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:

	Fiscal Year Ended
	October 29,		October 30,		October 31,
	2023		2022		2021
Risk-free Interest Rate	3.5	%	1.6	%	1.0	%
Dividend Yield	2.4	%	2.4	%	2.1	%
Stock Price Volatility	21.1	%	20.4	%	20.0	%
Expected Option Life	7.4 years		7.5 years		7.4 years

Schedule of reconciliation of the nonvested shares

A reconciliation of the restricted stock units as of October 29, 2023, is:

	Shares (in thousands)	Weighted- average Grant Date Fair Value		Weighted-average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Restricted Stock Units Outstanding at October 30, 2022	681	$	45.53
Granted	237	45.96
Dividend Equivalents	18	41.44
Vested	(185)	45.88
Forfeited	(28)	45.64
Restricted Stock Units Outstanding at October 29, 2023	723	$	45.59	1.3	$	22,692

A reconciliation of the restricted shares as of October 29, 2023, is:

	Shares (in thousands)	Weighted- average Grant Date Fair Value
Restricted Shares Outstanding at October 30, 2022	37	$	47.11
Granted	44	44.14
Vested	(37)	47.11
Restricted Shares Outstanding at October 29, 2023	44	$	44.14

Schedule of the weighted-average grant date fair value and fair value of nonvested shares granted

The weighted-average grant date fair value of restricted stock units granted, the total fair value of restricted stock units granted, and the fair value of restricted stock units that have vested are:

	Fiscal Year Ended
	October 29,		October 30,		October 31,
In thousands, except per share amounts	2023		2022		2021
Weighted-average Grant Date Fair Value	$	45.96	$	44.14	$	47.52
Fair Value of Restricted Stock Units Granted	10,889		15,980		10,699
Fair Value of Restricted Stock Units Vested	8,466		1,893		1,460

The weighted-average grant date fair value of restricted shares granted, the total fair value of restricted shares granted, and the fair value of shares that have vested are:

	Fiscal Year Ended
	October 29,		October 30,		October 31,
In thousands, except per share amounts	2023		2022		2021
Weighted-average Grant Date Fair Value	$	44.14	$	47.11	$	46.92
Fair Value of Restricted Shares Granted	1,920		1,760		1,760
Fair Value of Restricted Shares Vested	1,760		1,760		2,133